Ignite Creation Date:
2024-05-05 @ 5:16 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00420888
Status:
COMPLETED
Last Update Posted:
2015-07-22
First Post:
2007-01-09
Brief Title:
ABR-217620Naptumomab Estafenatox With Interferon-alpha IFN-alpha Compared to IFN-alpha Alone in Patients With Advanced Renal Cell Carcinoma
Sponsor:
Active Biotech AB
Organization:
Active Biotech AB
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-01
Start Date Type:
None
Primary Completion Date:
2013-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-01
Completion Date Type:
ACTUAL
First Submit Date:
2007-01-09
First Submit QC Date:
January 9 2007
Study First Post Date:
2007-01-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2014-06-02
Disp First Submit QC Date:
July 1 2014
Disp First Post Date:
2014-07-08
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2015-06-30
Last Update Post Date:
2015-07-22
Last Update Post Date Type:
ESTIMATED